1. Takada, H., Nakazawa, T., Ohara, H., Ando, T., Hayashi, K., Naito, I., Okumura, F., Tanaka, H., Yamada, T., Takahashi, S., Joh, T.: Role of osteopontin in calcification in autoimmune pancreatitis Dig Dis Sci, 54: 793-801, 2009.
2. Takahashi, S., Takeshita, K., Seeni, A., Sugiura, S., Tang, M., Sato, S., Kuriyama, H., Nakadate, M., Abe, K., Maeno, Y., Nagao M., Shirai, T.: Suppression of prostate cancer in a transgenic rat model via γ-tocopherol activation of caspase signaling. Prostate, 69: 644-651, 2009.
3. Harper, CE., Patel, BB., Cook, LM., Wang, J., Shirai, T., Eltoum, IA., Lamartiniere, CA.: Characterization of SV-40 Tag rats as a model to study prostate cancer. BMC Cancer, 9: 30, 2009.
4. Suzuki, S., Takeshita, K., Asamoto, M., Takahashi, S., Kandori, H., Tsujimura, K., Saito, F., Masuko, K., Shirai, T.: High mobility group box associated with cell proliferation appears to play an important role in hepatocellular carcinogenesis in rats and humans. Toxicology, 255: 160-170, 2009.
5. Takeuchi, M., Sasaki, S., Ito, M., Okada, S., Takahashi, S., Kawai, T., Suzuki, K., Oshima, H., Hara, M., Shibamoto, Y.: Urinary bladder cancer: diffusion-weighted MR imaging–accuracy for diagnosing T stage and estimating histologic grade. Radiology, 251: 112-121, 2009.
6. Inawaka, K., Kawabe, M., Takahashi, S., Doi, Y., Tomigahara, Y., Tarui, H., Abe, J., Kawamura, S., Shirai, T.: Maternal exposure to anti-androgenic compounds, vinclozolin, flutamide and procymidone, has no effects on spermatogenesis and DNA methylation in male rats of subsequent generations. Toxicol Appl Pharmacol, 237: 178-187, 2009.
7. Tanida, S., Kataoka, H., Kubota, E., Mori, Y., Sasaki, M., Ogasawara, N., Wada, T., Mizoshita, T., Shimura, T., Murakami, K., Mizushima, T., Hirata, Y., Okamoto, Y., Mabuchi, M., Ebi, M., Tanaka, M., Kamiya, T., Takahashi, S., Joh, T.: Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma. Int J Clin Oncol, 14: 266-269, 2009.
8. Ogawa, K., Nabae, K., Wang, J., Wake, K., Watanabe, S., Kawabe, M., Fujiwara, O., Takahashi, S., Ichihara, T., Tamano, S., Shirai, T.: Effects of gestational exposure to 1.95-GHz W-CDMA signals for IMT-2000 cellular phones: Lack of embryotoxicity and teratogenicity in rats. Bioelectromagnetics, 30: 205-212, 2009.
9. Tang, M., Asamoto, M., Ogawa, K., Naiki-Ito, A., Sato, S., Takahashi, S., Shirai, T.: Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor. Pathol. Int., 59: 790-796, 2009.
10. Sugiyama, M., Tanaka, Y., Kurbanov, F., Maruyama, I., Shimada, T., Takahashi, S., Shirai, T., Hino, K., Sakaida, I., Mizokami, M.: Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology, 136: 652-662, 2009.
11. Yamashita, H., Takahashi, S., Ito, Y., Yamashita, T., Ando, Y., Toyama, T., Sugiura, H.,Yoshimoto, N., Kobayashi, S., Fujii, Y., Iwase, H.: Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer. Cancer Sci, 100: 2028-2033, 2009.
12. Matsumoto, H., Yakabe, Y., Saito, K., Sumida, K., Sekijima, M., Nakayama, K., Miyaura, H., Saito, F., Otsuka, M., Shirai, T.: Discrimination of carcinogens by hepatic transcript profiling in rats following 28-day administration. Cancer Inform, 7: 253-269 2009.
13. Naitoh, I., Nakazawa, T., Ohara, H., Sano, H., Ando, T., Hayashi, K., Tanaka, H., Okumura, F., Miyabe, K., Yoshida, M., Takahashi, S., Joh, T.: Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy. Intern Med, 48: 2003-2007, 2009.
14. Said, MM., Ogawa, K., Pitchakarn, P., Takahashi, S., Asamoto, M., Shirai, T.: Cyclooxygenase 2 and prostaglandin E2 are not involved in N-nitrosodiethylamine-initiated early rat hepatocarcinogenesis. J Toxicol Pathol, 22: 263-271, 2009.
15. Futakuchi, M., Nannuru, KC., Varney, ML., Sadanandam, A., Nakao, K., Asai, K., Shirai, T., Sato, SY., Singh, RK.: Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci, 100: 71-81, 2009.
16. Long, N., Hardiville, S., Pierce, A., Fukamachi, K., Futakuchi, M., Alexander, DB., Shirai, T., Tsuda, H.: Construction of a multi-functional helper-dependent adenovirus based system for cancer gene therapy. Asian Pac J Cancer Prev, 10: 939-960, 2009.
17. Naitoh, I., Nakazawa, T., Ohara, H., Ando, T., Hayashi, K., Tanaka, H., Okumura, F., Takahashi, S., Joh, T.: Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol, 44:1147-1155, 2009.
18. Suzuki, S., Arnold, LL., Pennington, KL., Chen, B., Le, XC., Cohen, SM.: Effects of an epidermal growth factor receptor inhibitor on arsenic associated toxicity in the rat bladder epithelium. Toxicol Lett, 187: 124-129, 2009.
19. Suzuki, S., Arnold, LL., Pennington, KL., Kakiuchi-Kiyota, S., Cohen, SM.: Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium. Toxicology, 261: 41-46, 2009.
20. Kakiuchi-Kiyota, S., Vetro, JA., Suzuki, S., Varney, ML., Han, HY., Nascimento, M., Pennington, KL., Arnold, LL., Singh, RK., Cohen, SM.: Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouse. Toxicol Appl Pharmacol, 237: 83-90, 2009.